Cardiovascular Diseases Clinical Trial
Official title:
The Vascular Effects of Nitrite on Coronary Flow Under Normoxia and Hypoxia
This study is a pharmacodynamic proof of concept study investigating the physiological effects of systemic infusion of nitrite on coronary blood flow using MRI.
This is a healthy volunteer, proof of concept study.
The participant will have blood taken and this will be analysed for baseline levels of
nitrate, nitrite and nitroso species. They will then have a baseline MRI to assess coronary
flow in normoxia. Next, hypoxia will be induced using 12% oxygen/88% nitrogen. The
participant will then have a baseline MRI to assess coronary flow in hypoxia (3 breath-hold
image captures).
After all baseline images have been captured, the investigators will commence an intravenous
nitrite sodium infusion, dose 70μmol, of 5 minute duration (14μmol /min-1). At the 5th
minute, the participant have a further MRI image to assess coronary flow with the
intervention in normoxia (3 breath-hold image captures).
A 10-minute washout will follow (with the half-life of nitrite being documented as 110
seconds). There will be optional repeat 3 breath-hold image captures at 5 minutes and at 10
minutes.
Next hypoxia will be induced using 12% oxygen/88% nitrogen again. The investigators will
commence a second intravenous nitrite sodium infusion, dose 70μmol, 5 minute duration (14μmol
/min-1). At the 5th minute, the participant will have a further MRI image to assess coronary
flow with the intervention in hypoxia (3 breath-hold image captures).
At the end of the study the participant will have blood taken and this will be analysed for
repeat levels of nitrate, nitrite and nitroso species.
All interventions will be performed by fully trained and competent medical staff.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
Recruiting |
NCT04417387 -
The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
|
||
Not yet recruiting |
NCT06211361 -
Cardiac Rehabilitation Program in Patients With Cardiovascular Disease
|
N/A | |
Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
Recruiting |
NCT04514445 -
The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
|
||
Enrolling by invitation |
NCT04253054 -
Chinese Multi-provincial Cohort Study-Beijing Project
|
||
Completed |
NCT03273972 -
INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers
|
N/A | |
Completed |
NCT03680638 -
The Effect of Antioxidants on Skin Blood Flow During Local Heating
|
Phase 1 | |
Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
Completed |
NCT04083846 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)
|
Phase 1 | |
Completed |
NCT04083872 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)
|
Phase 1 | |
Completed |
NCT03619148 -
The Incidence of Respiratory Symptoms Associated With the Use of HFNO
|
N/A | |
Completed |
NCT03693365 -
Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
|
||
Completed |
NCT03466333 -
Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia
|
Phase 2 | |
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Completed |
NCT05132998 -
Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors
|
N/A | |
Completed |
NCT05067114 -
Solutions for Atrial Fibrillation Edvocacy (SAFE)
|